FDA Commissioner Scott Gottlieb, MD describes his plans for regulating digital health innovation, saying that the FDA “should carry out its mission to protect and promote the public health through policies that are clear enough for developers to apply them on their own, without having to seek out, on a case-by-case basis.”
The Office of the Chief Actuary of CMS forecasts a 13 million reduction in insured patients by 2026 if AHCA is passed, 10 million less than the CBO’s prediction.
Kaiser Permanente Medical Group CEO Robert Pearl, MD outlines the lessons he learned while working on the health system’s $4 billion Epic implementation.
Boston-based DNA sequencing company Veritas Genetics is offering full genome sequencing to parents in China. The sequencing report addresses 950 inherited diseases, as well as 200 genes connected to drug reactions, and 100 physical traits the child is likely to have.
STAT reports that behind-the-scenes discussions being held by the Trump administration on how to reign in drug prices are being influenced by lobbyists for the pharmaceutical industry.